bluebird

bluebird is a Massachusetts-based biotechnology company that discovers and develops gene therapies for the treatment of genetic diseases.

Business Model:

Revenue: $5.1M

Employees: 501-1,000

Detailed bluebird Information

Geographic Data

bluebird headquarters map

Address: 455 Grand Union Boulevard

City: Somerville

State: MA

Zip: 02145

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$75M

Raised Total:

$484M

Metrics

189,642Website Global Rank

384,806Website Monthly Traffic

Twitter Followers

Description

bluebird is a Massachusetts-based biotechnology company that discovers and develops gene therapies for the treatment of genetic diseases.

Contact Phone:
+13394999300

Contact Email:

bluebird went public on 6/14/2019 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/14/2019

Ticker Symbol:
BLUE

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
12/2017 TC BioPharm Series B 16M
12/2017 TC BioPharm Series B 0
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2023 Post-IPO Equity $120M
6/2013 IPO $116.1M
3/2011 Grant $4.2M
7/2012 Series D $0 ARCH Venture Partners
Third Rock Ventures
ArmaVir Partners
Deerfield Partners
RA Capital Management
Forbion Capital Partners
TVM Capital
ARCH Venture Partners
Third Rock Ventures
ArmaVir Partners
Deerfield Partners
RA Capital Management
Forbion Capital Partners
TVM Capital
10/2004 Venture Round 3 $12M Techno Venture Management
Easton Capital
ABN AMRO Fund
Techno Venture Management
4/2011 Series C 5 $30M Easton Capital
ARCH Venture Partners
ARCH Venture Partners
TVM Capital
Third Rock Ventures
Forbion Capital Partners
Easton Capital
ARCH Venture Partners
ARCH Venture Partners
9/2021 Post-IPO Equity $75M
3/2010 Series B 5 $35M Sanofi Ventures
Third Rock Ventures
TVM Capital
Forbion Capital Partners
Easton Capital
Sanofi Ventures
Third Rock Ventures
6/2004 Series A 2 $8.5M Nazem and Company
ABN AMRO Fund
10/2012 Venture Round 1 $9.3M California Institute for Regenerative Medicine
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine
1/2023 Post-IPO Equity $113.5M
12/2016 Post-IPO Equity $250M
7/2012 Series D 7 $60M Deerfield Partners
Rally Capital
ARCH Venture Partners
Third Rock Ventures
TVM Capital
Forbion Capital Partners
ARCH Venture Partners
Third Rock Ventures
ArmaVir Partners
Deerfield Partners
RA Capital Management
Forbion Capital Partners
TVM Capital
Announced Date Name Price
7/2014 Pregenen

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research